Skip to contentC
China Pharma Holdings, Inc.
C
CPHIChina Pharma Holdings, Inc. Q1 2015 · 10-Q
Revenue$5.69M$5.69M−19.9% vs Q1 2014 Net Income-$4.07M-$4.07MN/M vs Q1 2014 EPS Diluted-$0.09-$0.09N/M vs Q1 2014 Gross Profit$1,059,127−60.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
Operating Cash Flow-$2,239N/M Free Cash Flowderived-$2,239N/M Margins · derivedGross margin18.6%−18.8 pt vs Q1 2014
Operating margin-66.1%−33.2 pt vs Q1 2014
Net margin-71.5%−72.2 pt vs Q1 2014
ended Mar 31, 2015 · filed May 11, 2015 · 41 d after period end